“Amneal Ropivacaine Injection Recall: Particulate Matter Hazard.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/32132-amneal-ropivacaine-injection-recall-particulate-matter-hazard. Based on FDA recall #D-0402-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0402-2025%22&limit=1).
The FDA announced on April 17, 2025, that Amneal Pharmaceuticals voluntarily recalled Ropivacaine Hydrochloride Injection due to the presence of particulate matter. The Class I recall affects lots AL240003 and AL240004 with expiration dates of January 31, 2026.
How to tell if you have it
Brand: Amneal
Product: Ropivacaine Hydrochloride Injection, USP, 0.5%, 500 mg per 100 mL (5mg/mL)
NDC: 70121-1734-1 (bag); 70121-1734-3 (box)
Lot codes: AL240003, AL240004
Expiration: 01/31/2026
The hazard
The recall is due to the presence of particulate matter in the injection. The FDA classified this as a Class I recall, indicating a high risk of serious adverse health consequences or death.
Context
GovInfoNow's records show Amneal Pharmaceuticals has 9 other recalls on record since December 12, 2016. Other recent recalls include an Amneal Estradiol Gel recall for defective packets (September 8, 2026), an Amneal Primidone Tablets recall for cross-contamination risk (June 3, 2026), and an Amneal traMADol 50mg Tablets recall for NDSRI impurity risk (March 19, 2026). Other recent recalls of similar products include GE Healthcare Omnipaque Injection and Omnipaque 300 mg/mL Injection recalls for particulate matter hazard (March 24, 2026) and an American Regent Papaverine HCl Injection recall for particulate matter hazard (July 24, 2026).
How to tell if you have this one
Check the NDC numbers: 70121-1734-1 (bag) or 70121-1734-3 (box). The product was manufactured in India with lot numbers AL240003 or AL240004 and expires January 31, 2026.
Brand
Amneal
Category
Drug
Based on the official FDA remedy
What to do — step by step
Stop Using Now
Immediately stop using the recalled ropivacaine injection if you have it. Do not administer or inject the product.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the US” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 18 months after the firm started it.
1Firm started the recall
2FDA classified it Class I
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0402-2025 (April 17, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0402-2025 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.